Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             33 results found
no title author magazine year volume issue page(s) type
1 An epidemiologic survey of cardiovascular disease in women taking oral contraceptives Thorogood, Margaret
1990
163 1P2 p. 274-281
8 p.
article
2 Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Finland from 1975 to 1984 Hirvonen, Erkki
1990
163 1P2 p. 281-284
4 p.
article
3 Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease Gaspard, Ulysse J.
1990
163 1P2 p. 334-343
10 p.
article
4 Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: Relation to the development of cardiovascular disease Kelleher, Cecily C.
1990
163 1P2 p. 392-395
4 p.
article
5 Comparative studies of 30 μg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets Daly, Leisha
1990
163 1P2 p. 430-437
8 p.
article
6 Disorders of the hemostatic system and the risk of the development of thrombotic and cardiovascular diseases: Limitations of laboratory diagnosis Kluft, Cornelis
1990
163 1P2 p. 305-312
8 p.
article
7 Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: A one-year randomized, prospective, comparative trial Jandrain, Bernard J.
1990
163 1P2 p. 378-381
4 p.
article
8 Effects of long-term gestodene-containing oral contraceptive administration on hemostasis Abbate, Rosanna
1990
163 1P2 p. 424-429
6 p.
article
9 Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid Jespersen, Jørgen
1990
163 1P2 p. 396-403
8 p.
article
10 Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: The Telecom Study Simon, Dominique
1990
163 1P2 p. 382-387
6 p.
article
11 Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyI estradiol on lipid metabolism in comparison with two levonorgestrel preparations Kloosterboer, Helenius J.
1990
163 1P2 p. 370-373
4 p.
article
12 Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen Gram, Jørgen
1990
163 1P2 p. 438-442
5 p.
article
13 Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism Gevers Leuven, Jan A.
1990
163 1P2 p. 358-362
5 p.
article
14 Hemostasis profile in women taking low-dose oral contraceptives David, J.L.
1990
163 1P2 p. 420-423
4 p.
article
15 Impairment of glucose tolerance: Mechanism of action and impact on the cardiovascular system Beck-Nielsen, Henning
1990
163 1P2 p. 292-295
4 p.
article
16 Influence of oral contraceptives on coagulation tests in native blood and plasma Kunz, Friedebert
1990
163 1P2 p. 417-420
4 p.
article
17 Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular disease Juhan-Vague, Irene
1990
163 1P2 p. 313-315
3 p.
article
18 Introductory remarks Jespersen, Jorgen
1990
163 1P2 p. 273-
1 p.
article
19 Low-dose oral contraceptives and carbohydrate metabolism Godsland, Ian F.
1990
163 1P2 p. 348-353
6 p.
article
20 Mechanism of action of oral contraceptives on carbohydrate metabolism at the cellular level Skouby, Sven O.
1990
163 1P2 p. 343-348
6 p.
article
21 Metabolic changes during the normal menstrual cycle: A longitudinal study Lebech, Anne-Mette
1990
163 1P2 p. 414-416
3 p.
article
22 Metabolic changes during treatment with two different progestogens Refn, Hanne
1990
163 1P2 p. 374-377
4 p.
article
23 Oral contraceptives in risk groups: Exclusion or monitoring? Guillebaud, John
1990
163 1P2 p. 443-446
4 p.
article
24 Past use of oral contraceptives and cardiovascular disease: A meta-analysis in the context of the Nurses’ Health Study Stampfer, Meir J.
1990
163 1P2 p. 285-291
7 p.
article
25 Pharmacokinetics of gestagens: Some problems Fotherby, K.
1990
163 1P2 p. 323-328
6 p.
article
26 Protein binding of active ingredients and comparison of serum ethinyl estradiol sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ ethinyl estradiol (Femovan) or a combination of desogestrel/ ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives Hümpel, Michael
1990
163 1P2 p. 329-333
5 p.
article
27 Role of plasma lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects Tikkanen, Matti J.
1990
163 1P2 p. 296-304
9 p.
article
28 Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications Goldzieher, Joseph W.
1990
163 1P2 p. 318-322
5 p.
article
29 Some aspects of the relationship between oral contraceptives, lipid abnormalities, and cardiovascular disease Samsioe, Göran
1990
163 1P2 p. 354-358
5 p.
article
30 Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables Kooistra, Teake
1990
163 1P2 p. 404-413
10 p.
article
31 The clinical relevance of oral contraceptive pill-induced plasma lipid changes: Facts and fiction Hoppe, Gundolf
1990
163 1P2 p. 388-391
4 p.
article
32 Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives Kuhl, Herbert
1990
163 1P2 p. 363-369
7 p.
article
33 Why do we need pharmacokinetic studies? Hvidberg, Eigill F.
1990
163 1P2 p. 316-318
3 p.
article
                             33 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands